Animal models of chronic kidney disease: Useful but not perfect

Nephrology Dialysis Transplantation

Volumn 28, Issue 10, 2013, Pages 2432-2438

  Becker, Gavin J ^a   Hewitson, Tim D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

animal models; chronic kidney disease

Indexed keywords

ANIMAL TESTING REFINEMENT; CHRONIC KIDNEY DISEASE; DISEASE MODEL; DOG; FUNCTIONAL ANATOMY; MEDICAL RESEARCH; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RAT; RESEARCH ETHICS; REVIEW; RODENT; SPECIES DIFFERENCE; SWINE;

ANIMAL MODELS; CHRONIC KIDNEY DISEASE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84884956652     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft071     Document Type: Review

References (55)

1. Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. The National Academies Press, Washington, DC, 2011
2. Anders H-J, Schlondorff D. Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp Nephrol 2000; 8: 181-193 (Pubitemid 30665887)
3. Hewitson TD, Mookerjee I, Masterson R et al. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology 2007; 148: 660-669 (Pubitemid 46143169)
4. Gawlik A, Quaggin SE. Conditional gene targeting in the kidney. Curr Mol Med 2005; 5: 527-536 (Pubitemid 41086777)
5. Schnermann J. Micropuncture analysis of tubuloglomerular feedback regulation in transgenic mice. J Am Soc Nephrol 1999; 10: 2614-2619
6. Feng M, DiPetrillo K. Non-invasive blood pressure measurement in mice. Methods Mol Biol 2009; 573: 45-55
7. Festing MF. Inbred strains should replace outbred stocks in toxicology, safety testing, and drug development. Toxicol Pathol 2010; 38: 681-690
8. Nishino T, Sasaki N, Nagasaki K et al. Genetic background strongly influences the severity of glomerulosclerosis in mice. J Vet Med Sci 2010; 72: 1313-1318
9. Yan G, Zhang G, Fang X et al. Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol 2011; 29: 1019-1023
10. Campos-Neto A, Porrozzi R, Greeson K et al. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 2001; 69: 4103-4108 (Pubitemid 32493335)
11. Abitbol MM, Ober MB, Gallo GR et al. Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am J Pathol 1977; 86: 573-590 (Pubitemid 8063539)
12. Suzuki N, Suzuki M, Murakami K et al. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and nonhuman primates. Brain Res 2012; 1430: 93-100
13. Amatrudo JM, Weaver CM, Crimins JL et al. Influence of highly distinctive structural properties on the excitability of pyramidal neurons in monkey visual and prefrontal cortices. J Neurosci 2012; 32: 13644-13660
14. Wussow F, Yue Y, Martinez J et al. A Vaccine based on the rhesus cytomegalovirus ul128 complex induces broadly neutralizing antibodies in rhesus macaques. J Virol 2013; 87: 1322-1332
15. Coors ME, Glover JJ, Juengst ET et al. The ethics of using transgenic non-human primates to study what makes us human. Nat Rev Genet 2010; 11: 658-662
16. Chen Y, Niu Y, Ji W. Transgenic nonhuman primate models for human diseases: approaches and contributing factors. J Genet Genomics 2012; 39: 247-251
17. Kim J, Zarjou A, Traylor AM et al. In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice. Kidney Int 2012; 82: 278-291
18. Abel JJ, Rowntree LG, Turner BB. On the removal of diffusible substances from the circuclating blood of living animals by dialysis. J Pharmacol Exp Ther 1913; 5: 275-316
19. Tilney N. Transplant: From Myth to Reality. Yale University Press, New Haven, CT, USA 2003
20. Yarger WE, Griffith LD. Intrarenal hemodynamics following chronic unilateral ureteral obstruction in the dog. Am J Physiol 1974; 227: 816-826
21. Ekser B, Ezzelarab M, Hara H et al. Clinical xenotransplantation: the next medical revolution? Lancet 2012; 379: 672-683
22. Giraud S, Favreau F, Chatauret N et al. Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol 2011; 2011: 532127
23. Hewat T. The Florey: the story of the sheep hilton. Collins/Angus & Robertson, North Ryde, Sydney, Australia 1990
24. Treuting PM, Dintzis S. Comparative anatomy and histology: a mouse and human atlas. Academic Press, Elsevier, London, UK 2012
25. Hewitson TD, Ono T, Becker GJ. Small animal models of renal disease: a review. Methods Mol Biol 2009; 466: 41-57
26. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380: 756-766
27. Guan Z, Gobe G, Willgoss D et al. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide. Am J Physiol Renal Physiol 2006; 291: F619-F628 (Pubitemid 44343744)
28. Bucaloiu ID, Kirchner HL, Norfolk ER et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81: 477-485
29. Forbes JM, Hewitson TD, Becker GJ et al. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int 2000; 57: 2375-2385 (Pubitemid 30340736)
30. Breyer MD, Bottinger E, Brosius FC, III et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 27-45 (Pubitemid 43073154)
31. Alpers CE, Hudkins KL. Mouse models of diabetic nephropathy. Curr Opin Nephrol Hypertens 2011; 20: 278-284
32. Gurley SB, Clare SE, Snow KP et al. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 2006; 290: F214-F222
33. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80 (Pubitemid 43117741)
34. Gurley SB, Mach CL, Stegbauer J et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol 2010; 298: F788-F795
35. Soler MJ, Riera M, Batlle D. New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res 2012; 2012: 616313
36. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol. 2005; 16: 1711-1722 (Pubitemid 41716477)
37. Stevenson FT, Kaysen GA. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.Wien Klin Wochenschr 1999; 111: 307-314 (Pubitemid 29207086)
38. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005; 22: 359-370 (Pubitemid 40516231)
39. Tan SM, Zhang Y, Cox AJ et al. Tranilast attenuates the upregulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. Nephrol Dial Transplant 2011; 26: 100-110
40. Cochrane AL, Kett MM, Samuel CS et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 2005; 16: 3623-3630 (Pubitemid 46211283)
41. Takemoto SK, Arns W, Bunnapradist S et al. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation 2008; 86: 18-25
42. Hewitson TD, Ho WY, Samuel CS. Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis. Endocrinology 2010; 151: 4938-4948
43. Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002; 13: 2464-2477
44. Strauch M, Gretz N. Animal models to induce renal failure: a historical survey. Contrib Nephrol 1988; 60: 1-8
45. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 2003; 64: 350-355 (Pubitemid 36714190)
46. Fujimoto T, Okada M, Kondo Y et al. The nature of masugi nephritis. Acta Pathol Jpn 1964; 14: 275-310
47. Steblay RW, Rudofsky U. Autoimmune glomerulonephritis induced in sheep by injections of human lung and Freund's adjuvant. Science 1968; 160: 204-206
48. Mosley K, Collar J, Cattell V. Mesangial cell necrosis in Thy 1 glomerulonephritis-an ultrastructural study. Virchows Arch 2000; 436: 567-573 (Pubitemid 30406639)
49. Imai H, Nakamoto Y, Asakura K et al. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985; 27: 756-761 (Pubitemid 15064635)
50. Berthelot L, Papista C, Maciel TT et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 2012; 209: 793-806
51. Farquhar MG, Saito A, Kerjaschki D et al. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J Am Soc Nephrol 1995; 6: 35-47
52. Glassock RJ. Human idiopathic membranous nephropathy-a mystery solved? N Engl J Med 2009; 361: 81-83.
53. Jefferson JA, Pippin JW, Shankland SJ. Experimental models of membranous nephropathy. Drug Discov Today Dis Models 2010; 7: 27-33
54. Prunotto M, Carnevali ML, Candiano G et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21: 507-519
55. Park F. Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics 2007; 31: 159-173. (Pubitemid 350014393)